99%+ Purity
COA Included
Sealed Vials
PT-141
Melanocortin agonist for libido enhancement
Libido
Key Benefits
- Central brain-based mechanism of action
- May enhance natural sexual motivation pathways
- Works independently of hormonal status
- Rapid onset within 45-60 minutes
- Effects may persist 6-12 hours
- Targets melanocortin receptor system
- Supported by clinical research data
Reignite Sexual Desire From Where It Actually Starts—Your Brain
Most libido treatments target blood flow or hormones and miss the real problem—your brain's arousal circuits aren't firing properly. PT-141 works directly on the neural pathways that control sexual motivation and desire, so you get results even when everything else has failed. This is desire enhancement from the source, not a band-aid solution.
Melanocortin receptor system / Hypothalamic sexual motivation pathways (MC3R/MC4R activation)
About PT-141
PT-141 is a selective melanocortin receptor agonist that directly activates the brain's natural sexual desire pathways. Unlike treatments that work peripherally, this peptide targets the hypothalamic circuits responsible for sexual motivation and arousal. Effects typically begin within 45-60 minutes and can last 6-12 hours.
Who It's For
Ideal for individuals experiencing diminished sexual desire that hasn't responded to hormonal or vascular treatments. PT-141's brain-based mechanism works independently of testosterone levels or physical function, making it particularly valuable for desire disorders with neurochemical origins. Best utilized as an on-demand protocol for significant events rather than daily administration.
Research Background
PT-141 represents a breakthrough in understanding how sexual desire and arousal are regulated at the neurobiological level. Unlike traditional treatments that focus on physical aspects of sexual function, PT-141 targets the brain's natural arousal pathways through the melanocortin system - the same neural network involved in appetite, mood, and reward processing. This central mechanism explains why the peptide can enhance sexual desire even when other treatments have failed.
Research has focused on two primary areas: 1) Understanding the precise neural circuits activated by melanocortin receptor stimulation in sexual behavior, and 2) Clinical applications for various forms of sexual dysfunction, particularly hypoactive sexual desire disorder. The peptide's unique ability to work independently of hormonal status or vascular function makes it particularly valuable for individuals whose sexual concerns stem from neurochemical rather than physical factors. Current research continues to explore optimal dosing protocols, long-term effects, and potential applications in broader populations beyond the currently approved indication.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 0.5 mg | |
Intermediate | 1 mg | |
Advanced | 1.25-1.75 mg | |
Maximum | 2 mg |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
4
36.0 mg needed ÷ 10 per vial
Total Investment
$140
$35.00 per vial
Per Dose
0.20 mL
20 units on U-100 syringe
Doses per Vial
10
10 ÷ 1.00 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
PT-141
$35.00